A method for the identification of a composition useful in the treatment of an
overweight or obese person to reduce the person's
body mass index is provided which comprises obtaining an extract of an ethnobotanical
plant, and evaluating the activity of the extract in an
assay selected from the group consisting of a
lipolysis assay, an
assay that measures the amount of
glycerol introduced by a
cell into a suspension medium of the
cell, an
adipocyte differentiation assay, an assay that measures the level of the
enzyme glycerol-3-
phosphate dehydrogenase, an assay that measures the inhibition of differentiation of preadipocytes to adipocytes, an assay that measures the accumulation of lipid in an
adipocyte, an assay that measures the de-differentiation of adipocytes into preadipocytes, and combinations thereof.
Sclareol and
sclareol-like compounds and
sclareolide and
sclareolide-like compounds are identified as useful in the treatment of
overweight and obese conditions and disorders and conditions associated with
adipose tissue abnormalities. These compounds can be formulated for
oral administration.